Abstract Library

#2165 A Pilot Study of the Cyclin Dependent Kinases 4, 6 Inhibitor Ribociclib in Patients with Foregut Neuroendocrine Tumors

Introduction: Increased cyclin dependent kinases 4, 6 (cdk 4/6) activity is noted in the majority of well differentiated foregut neuroendocrine tumors (fNETs) due to mutations in MENIN and other aberrations. These tumors also have preserved Rb function making cdk 4/6 inhibitors attractive agents for therapy.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Dasari A

Authors: Dasari A, Halperin D, Coya T, Mahvash A, Zorrilla I,

Keywords: Foregut NETs, ribociclib, cdk 4/6,

#1384 Gastroenteropancreatic Neuroendocrine Tumors. Ten Year Experience at Instituto Oncologico Nacional. Panama 2004-2015.

Introduction: Gastroenteropancreatic neuroendocrine tumours (GEP-NET) are rare neoplasm with a rising incidence worldwide.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Castillo-Fernandez O, Vergara R, Moreno-Ríos J, Cukier M, Tapia H,

Keywords: grade, prognosis, neuroendocrine tumor,